Preliminary studies point out conolidine may possibly inhibit distinct ion channels, lowering neuronal excitability and limiting soreness signals. This system is especially relevant in neuropathic pain, wherever irregular signaling causes persistent pain. Furthermore, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to